To the Editor: A new medication, Aggrenox, a formulation of aspirin and extended-release dipyridamole, is being actively marketed to physicians for the treatment of patients with transient ischemic attacks and ischemic stroke. Physicians involved in pharmacological stress testing should be aware that patients taking this medicine may also be referred for pharmacological stress perfusion testing...